Growing community of inventors

San Diego, CA, United States of America

George F Widhopf, Ii

Average Co-Inventor Count = 3.67

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 83

George F Widhopf, IiThomas James Kipps (11 patents)George F Widhopf, IiBing Cui (11 patents)George F Widhopf, IiJian Yu (4 patents)George F Widhopf, IiLiguang Chen (4 patents)George F Widhopf, IiCharles E Prussak (3 patents)George F Widhopf, IiCharles Prussak (1 patent)George F Widhopf, IiGeorge F Widhopf, Ii (11 patents)Thomas James KippsThomas James Kipps (35 patents)Bing CuiBing Cui (13 patents)Jian YuJian Yu (19 patents)Liguang ChenLiguang Chen (7 patents)Charles E PrussakCharles E Prussak (11 patents)Charles PrussakCharles Prussak (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of California (11 from 15,458 patents)


11 patents:

1. 12222355 - Therapeutic antibodies against ROR-1 protein and methods for use of same

2. 12162950 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

3. 11536727 - Therapeutic antibodies against ROR-1 protein and methods for use of same

4. 11312787 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

5. 10900973 - Therapeutic antibodies against ROR-1 protein and methods for use of same

6. 10627409 - Therapeutic antibodies against ROR-1 protein and methods for use of same

7. 10344096 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

8. 9933434 - Therapeutic antibodies against ROR-1 protein and methods for use of same

9. 9758591 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

10. 9523695 - Therapeutic antibodies against ROR-1 protein and methods for use of same

11. 9217040 - Therapeutic antibodies against ROR-1 protein and methods for use of same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…